Comment by dfsegoat

How should the average researcher go about replicating something like 3-5 clinical trials that a drug company may have run for a human drug?

Should we replicate all that work? Or perhaps just obtain the raw, patient-level data from said company and analyze the data ourselves?

I am just curious which you view as more efficacious?